{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success#webpage",
"url": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success",
"name": "From trial to market: Strategic site selection for biotech success",
"description": "Explore how strategic site selection in clinical trials drives biotech success from early development through commercialization. Learn how site feasibility in clinical trials and investigator site selection strategies help identify high-performing sites aligned with study goals. Explore how clinical trial country selection strategy and global site selection in biotech trials support efficient patient access and optimized geographic distribution. Learn how clinical trial site performance analytics and patient recruitment site selection improve decision-making, reduce delays, and enhance trial outcomes. By combining data-driven insights with a biotech-focused site strategy, organizations can improve trial execution, accelerate timelines, and deliver more efficient clinical development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "From trial to market: Strategic site selection for biotech success",
"item": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success#article",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success#webpage"
},
"headline": "Strategic Site Selection in Clinical Trials for Biotech Success and Trial Efficiency | Fortrea Insights",
"description": "Explore how strategic site selection in clinical trials drives biotech success from early development through commercialization. Learn how site feasibility in clinical trials and investigator site selection strategies help identify high-performing sites aligned with study goals. Explore how clinical trial country selection strategy and global site selection in biotech trials support efficient patient access and optimized geographic distribution. Learn how clinical trial site performance analytics and patient recruitment site selection improve decision-making, reduce delays, and enhance trial outcomes. By combining data-driven insights with a biotech-focused site strategy, organizations can improve trial execution, accelerate timelines, and deliver more efficient clinical development.",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-03",
"dateModified": "2025-07-03",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-07/from-trial-to-market-strategic-site-selection-biotech-success.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success#webpage",
"url": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success",
"name": "From trial to market: Strategic site selection for biotech success",
"description": "Explore how strategic site selection in clinical trials drives biotech success from early development through commercialization. Learn how site feasibility in clinical trials and investigator site selection strategies help identify high-performing sites aligned with study goals. Explore how clinical trial country selection strategy and global site selection in biotech trials support efficient patient access and optimized geographic distribution. Learn how clinical trial site performance analytics and patient recruitment site selection improve decision-making, reduce delays, and enhance trial outcomes. By combining data-driven insights with a biotech-focused site strategy, organizations can improve trial execution, accelerate timelines, and deliver more efficient clinical development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "From trial to market: Strategic site selection for biotech success",
"item": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success#article",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/trial-market-strategic-site-selection-biotech-success#webpage"
},
"headline": "Strategic Site Selection in Clinical Trials for Biotech Success and Trial Efficiency | Fortrea Insights",
"description": "Explore how strategic site selection in clinical trials drives biotech success from early development through commercialization. Learn how site feasibility in clinical trials and investigator site selection strategies help identify high-performing sites aligned with study goals. Explore how clinical trial country selection strategy and global site selection in biotech trials support efficient patient access and optimized geographic distribution. Learn how clinical trial site performance analytics and patient recruitment site selection improve decision-making, reduce delays, and enhance trial outcomes. By combining data-driven insights with a biotech-focused site strategy, organizations can improve trial execution, accelerate timelines, and deliver more efficient clinical development.",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-03",
"dateModified": "2025-07-03",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-07/from-trial-to-market-strategic-site-selection-biotech-success.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
Review Article